Skip to main content
. 2017 Jun 7;12(6):e0177919. doi: 10.1371/journal.pone.0177919

Table 2. Tasmanian devil serum ERBB3 and clinical history.

Devil Serum Erbb3 (pg/ml) Weight (Kg) Serum transit (days) clinical history BCS (0–5) DFT1 strain DFT1 1o No (range cm) Mets No
1 155 N/A 1 CHD, NAD
2 663 N/A 1 CHD, Localised alopecia
3 207 OW 1 CHD, Multiple punctures
4 313 N/A 1 CHD, Multiple punctures
5 291 N/A 1 CHD, Multiple minor wounds
6 <30 N/A 1 CHD, Few wounds, lactating
7 <30 N/A 2 CHD, N/A
8 <30 6 1 CHD, Great condition
9 220 10.5 1 CHDD, Abscess/scab on face
10 92 N/A 2 CHDD, Abscess left neck.
11 <30 4.7 1 CHDD, Skin tag on left ear
12 <30 N/A 1 CHDD, Dermatitis upper flank
13 <30 4.2 1 CHJD, Health check
14 32 3.4 1 CHJD, Health check
15 <30 4.6 1 CHJD, Health check.
16 18,254 N/A 1 DFT1, weak 2 2 2 (1.0–2.5) 3
17 999 6.1 3 DFT1, Reared 4 young 2 3 4 (1.0–1.5) 5
18 11,090 4.8 1 DFT1, Poor body condition 1–2 1 4 (2.0–3.0) 1
19 1903 3.7 1 DFT1, Emaciated disorientated 0 1 2 (1.6–5.2) 10
20 10,247 10 3 DFT1, Multiple lesions 3 2 4 (1.0–2.0) 2
21 1241 5 3 DFT1, Poor body condition 2.5 2 3 (1.0–1.5) 1
22 4198 9.3 4 DFT1, Advanced DFT1 2 4 7 (1.0–2.5) 0
23 766 N/A 1 DFT1, Emaciated 2 1 7 (1.0–4.7) 1
24 4383 6.7 1 CL, Generalised alopecia N/A
25 <30 8.2 1 CL, cutaneous plaques chest N/A
26 <30 8.0 1 CL, percutaneous plaque N/A
27 2008 5.9 1 CL, Skin lesions N/A
28 837 5.9 1 CL, Alopecia Poor
29 9703 5.3 1 CL, Generalised alopecia Poor
30 2403 8.2 1 CL, Alopecia ventrally N/A
31 536 7.4 1 CL, Alopecia left neck, pouch N/A
32 962 6.7 1 CL, Alopecia ventrally N/A
33 11,837 5.4 1 CL, Widespread alopecia 1–2
34 207 5.7 1 CL, Multifocal dermatitis, cutaneous lump (acanthoma) Poor
35 20,021 N/A 1 CL, Multifocal alopecia N/A

N/A not available, NAD no abnormality detected, OW over weight, BCS—body condition score, DFT1 strain–cytogenetically determined strain, DFT1 1o No–number and size of primary tumours recorded, Mets No—number of metastasis recorded, CHD clinically healthy devil, CHDD clinically healthy devil with dermatopathy, CHJD clinically healthy juvenile devil, DFT1 devil facial tumour 1, CL cutaneous lymphoma